RxDoctor Payments Data

Samantha Wong

Optometrist · Iselin, NJNPI 1295385193

Payments from drug & device makers

$4,423in general payments, 2019–2025

Across 60 payments — averaging $73.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$654
  • AbbVie$518
  • Glaukos Corporation$442
  • Sun Pharmaceutical Industries Inc.$428
  • Sight Sciences, Inc.$426
  • Tarsus Pharmaceuticals, Inc.$224
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$4,403100%
  • Gifts$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,423 in reported general payments places this provider in the 90th percentile of 1,357 optometrist providers in New Jersey.

See all optometrist providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
XiidraLifitegrast250$180,263
MieboPerfluorohexyloctane/Pf29$20,976
RestasisCyclosporine12$14,224
LumiganBimatoprost38$9,551
ZerviateCetirizine Hcl11$4,288
TobradexTobramycin/Dexamethasone13$3,716
Cyclosporine17$2,240
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol14$1,819
Brimonidine Tartrate34$1,809
Azelastine Hcl243$1,434
Latanoprost167$1,012
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat46$583
Ketorolac Tromethamine13$322
Timolol Maleate14$187

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bausch & Lomb Americas Inc.Xiidra, Miebo$654$201,239279 claims
AbbVieRestasis, Lumigan$518$23,77650 claims
Eyevance Pharmaceuticals LLCZerviate$150$4,28811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,357 optometrist providers in New Jersey.

Other optometrist in Iselin

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →